News

InSphero Launches 3D Mitochondrial Toxicity Testing Service New contract screening offering combines advanced 3D liver microtissue models and Agilent XFe96 Analyzer to identify mitochondrial liabilities

Registration Open for New Frontiers in 3D Cell Culture-based Screening Technologies Conference Schlieren, Switzerland, July 13, 2016 – Inaugural meeting, organized by InSphero AG, NCATS,

InvitroCue Commences Pancreatic Toxicity Assay Development 11 July 2016 – InvitroCue (ASX:IVQ), a leader in advanced bio-analytics, has progressed its technology in modeling multi-organ toxicity

Nature Scientific Reports Article Touts Versatility, Promise of 3D Human Liver Microtissues for Drug Development Schlieren, Switzerland, June 16, 2016 – Liver spheroids display longer

InSphero Launches Multi-donor Human Liver Microtissues for Prediction of Drug-induced Liver Injury Schlieren, Switzerland, March 16, 2016 – 3D human liver microtissues comprised of pooled

InSphero Contributes 3D Microtissue-based Assay Chapter to NCATS/NIH Assay Guidance Manual Schlieren, Switzerland, February 10, 2016 – Latest update of industry manual for development of

InSphero Inc. Streamlines 3D Microtissue Business Operations in the US Schlieren, Switzerland, February 01, 2016 – US subsidiary of Swiss-based InSphero AG initiates direct product

InSphero and NCATS to Present Collaborative 3D Cancer Screening Study at SLAS2016 Annual Meeting Schlieren, Switzerland, January 25, 2016 – Study describes high-throughput compatible screening

InSphero Adds Head of Sales, Expands Global Sales Team Schlieren, Switzerland, January 21, 2016 – Beate Schnell, Ph.D. joins senior team at global leader in

InSphero’s CEO Jan Lichtenberg wins Entrepreneur of the Year™ 2015 Schlieren, Switzerland, Oct 23, 2015 – Dr. Jan Lichtenberg, CEO and co-founder of InSphero AG

InSphero Receives € 750K Funding from EU-ToxRisk Consortium Schlieren, Switzerland, Oct 21, 2015 – In a large (€ 30 MM) H2020-supported collaborative project, leading 3D

InSphero Adds Chief Financial Officer to Senior Management Team Schlieren, Switzerland, Oct 15, 2015 – Oliver Krähenbühl brings 25 years of finance experience in the